(Q46404278)

21 December 2017

title

Is bladder biopsy necessary at three or six months post BCG therapy? (English)

1 reference

21 December 2017

author name string

Ralph A Highshaw

1

1 reference

21 December 2017

Stacy T Tanaka

2

1 reference

21 December 2017

Christopher P Evans

3

1 reference

21 December 2017

Ralph W deVere White

4

1 reference

21 December 2017

publication date

1 May 2003

1 reference

21 December 2017

published in

Urologic Oncology

1 reference

21 December 2017

volume

21

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

207-209

1 reference

21 December 2017

Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900239-9

7 January 2021

Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900239-9

7 January 2021

The management of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900239-9

7 January 2021

Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900239-9

7 January 2021

The treated natural history of high risk superficial bladder cancer: 15-year outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900239-9

7 January 2021

10.1016/S1078-1439(02)00239-9

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

12810207

1 reference

21 December 2017